The US Food and Drug Administration (FDA) has issued a safety communication warning against the use of laparoscopic power morcellation for hysterectomy or myomectomy (uterine fibroid removal). Of concern are reports of the spread of unsuspected cancerous tissue, specifically, uterine sarcoma, during laparoscopic hysterectomy.Laparoscopic power morcellation lawsuits have now been filed by women alleging they were harmed by the use of a power morcellator during laparoscopic hysterectomy.
READ MORE Dangerous Medical Devices LEGAL NEWS
Laparoscopic power morcellation has been marketed as a non-invasive hysterectomy or myomectomy. The surgery is used in women who are undergoing a hysterectomy or myomectomy for uterine fibroids. Power morcellation is a procedure that uses a medical device to break the uterine tissue into smaller pieces so it can be removed through a small incision in the patient's abdomen. Uterine fibroids are typically non-cancerous growths in the uterus that do not generally cause health problems but can cause pelvic pressure, pain and prolonged menstrual bleeding.
According to the FBI investigation, J&J was first made aware of the risks associated with the power morcellator in 2006, but didn’t pull the device from the market until July 2014.